Causative mechanisms for keloid formation
Active Grant Awarded Last action
- Award ID
- R01AR082440
- Recipient
-
University Of Connecticut Health Center UEI H6D6JMXJXDE6
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,709,684
Award facts
- Assistance listing
- 93.AR1 Arthritis, Musculoskeletal and Skin Diseases Research - Research Projects
- Completion date 59% complete
- Place of performance
- Farmington, CT 06030, USA
Award details come from USAspending.gov.
Description
- Abstract
- Keloids are dermal lesions that grow beyond the margin of the original wound in a tumor-like manner. Keloids can expand for several years, grow to large size and be painful, itchy and inflamed. Despite of the severe physical, psychological and social impact on patients, keloids are understudied and the treatment is unsatisfactory with high recurrence rates. Keloids also contribute to racial disparity in research and health care because prevalence is highest in populations of african ancestry. There is strong evidence for a genetically diverse basis for keloids. However, gene mutations that make patients susceptible and initiate keloids have not been identified. Identifying such causative genetic variants is fundamental for the understanding of keloid pathoetiology and for the identification of potential therapeutic targets. We previously identified several keloid candidate variants by linkage analysis and whole exome sequencing in a large cohort of 103 ethnic yoruba families from nigeria with heritable keloid formation. We prioritized four candidate genes variants that segregate in families, are expressed in skin and associated with other fibroproliferative disorders or are involved in wound healing. In this application we aim to determine whether the downstream effects of these four candidate gene variants induce a keloid-like phenotype in skin cells or in organotypic skin equivalents. We will investigate pathways by which the candidate variants act on skin cells. In aim 1, we will study the roles of keloid candidate gene variants on individual skin cell types derived from human isogenic induced pluripotent stem cells (HIPSCS) carrying the respective gene mutations. We minimize background noise from biological variability by comparing isogenic mutant and wild type cells that differ only by the variant to be investigated. In aim 2, we examine interactions between mutant fibroblasts, keratinocytes and macrophages that lead to paracrine effects guiding epithelial-mesenchymal transition and fibrosis during wound healing, using CO-cultures, organotypic skin equivalents and xenotransplant mouse models. We expect that investigating the role of genes that have not been investigated in keloids will bridge knowledge gaps in keloid and wound healing research and will identify novel factors that put individuals at risk for keloid development.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $42,562 | |
| Amendment | $383,065 | |
| Amendment | $21,818 | |
| Amendment | $392,705 | |
| Amendment | $30,439 | |
| Amendment | $391,357 | |
| Original award | $447,738 |
Quick answers
Who received award R01AR082440?
R01AR082440 was awarded to University Of Connecticut Health Center by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on December 20, 2023.
How much is award R01AR082440 worth?
$1,709,684 has been obligated on R01AR082440.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award